Z. Hausen, H. Villiers, and E. , Cancer ???Causation??? by Infections???Individual Contributions and Synergistic Networks, Seminars in Oncology, vol.41, issue.6, pp.860-75, 2015.
DOI : 10.1053/j.seminoncol.2014.10.003

A. Söderlund-strand, I. Uhnoo, and J. Dillner, Change in Population Prevalences of Human Papillomavirus after Initiation of Vaccination: The High-Throughput HPV Monitoring Study, Cancer Epidemiology Biomarkers & Prevention, vol.23, issue.12, pp.2757-2765, 2014.
DOI : 10.1158/1055-9965.EPI-14-0687

E. Kelly and S. Russell, History of Oncolytic Viruses: Genesis to Genetic Engineering, Molecular Therapy, vol.15, issue.4, pp.651-660, 2007.
DOI : 10.1038/sj.mt.6300108

G. Dunn, L. Old, and R. Schreiber, The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, pp.329-60, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104803

N. Mideo, Parasite adaptations to within-host competition, Trends in Parasitology, vol.25, issue.6, pp.261-269, 2009.
DOI : 10.1016/j.pt.2009.03.001

S. Gupta, N. Ferguson, and R. Anderson, Chaos, Persistence, and Evolution of Strain Structure in Antigenically Diverse Infectious Agents, Science, vol.280, issue.5365, p.795, 1998.
DOI : 10.1126/science.280.5365.912

R. Poulin and S. Morand, The Diversity of Parasites, The Quarterly Review of Biology, vol.75, issue.3, pp.277-293, 2000.
DOI : 10.1086/393500

R. Poulin, Evolutionary ecology of parasites, 2007.
DOI : 10.1515/9781400840809

M. Vesely, M. Kershaw, R. Schreiber, and M. Smyth, Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-71, 2011.
DOI : 10.1146/annurev-immunol-031210-101324

G. Bindea, B. Mlecnik, W. Fridman, F. Pagès, and J. Galon, Natural immunity to cancer in humans, Current Opinion in Immunology, vol.22, issue.2, pp.215-237, 2010.
DOI : 10.1016/j.coi.2010.02.006

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011.
DOI : 10.1016/j.cell.2011.02.013

A. Ingels, T-helper 1 immunoreaction influences survival in muscleinvasive bladder cancer: proof of concept, Ecancermedicalscience, vol.8, p.486, 2014.

O. Haabeth, Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer, Nature Communications, vol.65, p.240, 2011.
DOI : 10.1093/jnci/80.17.1393
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072106

L. Vella, Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer, Proceedings of the National Academy of Sciences, vol.204, issue.4, pp.14010-14015, 2009.
DOI : 10.1084/jem.20062387

P. Kidd and . Th1, Th2 balance: the hypothesis, its limitations, and implications for health and disease, Altern Med Rev, vol.8, pp.223-269, 2003.

B. Lippitz, Cytokine patterns in patients with cancer: a systematic review, The Lancet Oncology, vol.14, issue.6, pp.218-246, 2013.
DOI : 10.1016/S1470-2045(12)70582-X

A. Kimura and T. Kishimoto, IL-6: Regulator of Treg/Th17 balance, European Journal of Immunology, vol.8, issue.7, pp.1830-1835, 2010.
DOI : 10.1002/eji.201040391

H. Zaghouani, C. Hoeman, and B. Adkins, Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells, Trends in Immunology, vol.30, issue.12, pp.585-91, 2009.
DOI : 10.1016/j.it.2009.09.002

C. A. Janeway, P. Travers, M. Walport, and M. J. Shlomchik, The immune system in health and disease, 2001.

D. Cramer and A. L. , Mumps and ovarian cancer: modern interpretation of an historic association, Cancer Causes & Control, vol.180, issue.3, pp.1193-201, 2011.
DOI : 10.1007/s10552-010-9546-1

D. Blackwell, M. Hayward, and E. Crimmins, Does childhood health affect chronic morbidity in later life?, Social Science & Medicine, vol.52, issue.8, pp.1269-84, 2001.
DOI : 10.1016/S0277-9536(00)00230-6

M. Greaves, Infection, immune responses and the aetiology of childhood leukaemia, Nature Reviews Cancer, vol.76, issue.2, pp.193-203, 2006.
DOI : 10.1038/nrc1816

X. Ma, Daycare attendance and risk of childhood acute lymphoblastic leukaemia, British Journal of Cancer, vol.25, issue.9, p.6600274, 2003.
DOI : 10.1038/sj.bjc.6600274
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375371

S. Parodi, Childhood infectious diseases and risk of leukaemia in an adult population, International Journal of Cancer, vol.65, issue.8, pp.1892-1901, 2013.
DOI : 10.1002/ijc.28205

S. Crouch, Infectious Illness in Children Subsequently Diagnosed With Acute Lymphoblastic Leukemia: Modeling the Trends From Birth to Diagnosis, American Journal of Epidemiology, vol.176, issue.5
DOI : 10.1093/aje/kws180

G. Mastrangelo, Lung Cancer Risk: Effect of Dairy Farming and the Consequence of Removing that Occupational Exposure, American Journal of Epidemiology, vol.161, issue.11, pp.1037-1083, 2005.
DOI : 10.1093/aje/kwi138

R. Rylander, Endotoxin in the environment ??? exposure and effects, Journal of Endotoxin Research, vol.8, issue.4, pp.241-52, 2002.
DOI : 10.1179/096805102125000452

U. Iheagwara, Influenza Virus Infection Elicits Protective Antibodies and T Cells Specific for Host Cell Antigens Also Expressed as Tumor-Associated Antigens: A New View of Cancer Immunosurveillance, Cancer Immunology Research, vol.2, issue.3, pp.263-73, 2015.
DOI : 10.1158/2326-6066.CIR-13-0125

O. Landgren and J. Rapkin, Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia, Blood, vol.109, issue.5, pp.2198-201, 2007.
DOI : 10.1182/blood-2006-08-044008
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801057

L. Anderson, O. Landgren, and E. Engels, Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia, British Journal of Haematology, vol.40, issue.4, pp.444-453, 2010.
DOI : 10.1111/j.1365-2141.2009.07849.x

V. Thomas-vaslin, Immunodepression and Immunosuppression During Aging, 2009.
DOI : 10.5772/29549
URL : http://www.intechopen.com/download/pdf/29070

T. Fulop, Potential role of immunosenescence in cancer development, Annals of the New York Academy of Sciences, vol.130, issue.Suppl. 3
DOI : 10.1111/j.1749-6632.2009.05370.x

S. Vasto, Inflammation, ageing and cancer, Mechanisms of Ageing and Development, vol.130, issue.1-2, pp.40-45, 2009.
DOI : 10.1016/j.mad.2008.06.003

U. Hobohm, Toward general prophylactic cancer vaccination, BioEssays, vol.9, issue.10, pp.1071-1080, 2009.
DOI : 10.1002/bies.200900025

S. Russell, Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy, Mayo Clinic Proceedings, vol.89, issue.7, pp.926-959, 2014.
DOI : 10.1016/j.mayocp.2014.04.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225126

P. Rothwell, Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials, The Lancet, vol.379, issue.9826, pp.1591-601, 2012.
DOI : 10.1016/S0140-6736(12)60209-8

T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi, and C. Chitambar, The anti-malarial artesunate is also active against cancer, International Journal of Oncology, 2001.
DOI : 10.3892/ijo.18.4.767

R. Lamb, Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease, Oncotarget, vol.6, issue.7, pp.4569-84, 2015.
DOI : 10.18632/oncotarget.3174
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467100

M. Villumsen, Risk of lymphoma and leukaemia after bacille Calmette-Gu??rin and smallpox vaccination: A Danish case-cohort study, Vaccine, vol.27, issue.49, pp.6950-6958, 2009.
DOI : 10.1016/j.vaccine.2009.08.103

G. Mastrangelo, Does yellow fever 17D vaccine protect against melanoma?, Vaccine, vol.27, issue.4, pp.588-91, 2009.
DOI : 10.1016/j.vaccine.2008.10.076

J. Grange, J. Stanford, C. Stanford, and K. Ko, Vaccination strategies to reduce the risk of leukaemia and melanoma, JRSM, vol.96, issue.8, pp.389-92, 2003.
DOI : 10.1258/jrsm.96.8.389

B. Krone, K. Kölmel, B. Henz, and J. Grange, Protection against melanoma by vaccination with Bacille Calmette-Gu??rin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control, European Journal of Cancer, vol.41, issue.1, pp.104-121, 2005.
DOI : 10.1016/j.ejca.2004.08.010

K. Kölmel, Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients, European Journal of Cancer, vol.41, issue.1, pp.118-143, 2005.
DOI : 10.1016/j.ejca.2004.09.023

A. Pedersen and A. Fenton, Emphasizing the ecology in parasite community ecology, Trends in Ecology & Evolution, vol.22, issue.3, pp.133-142, 2007.
DOI : 10.1016/j.tree.2006.11.005

H. Getahun, C. Gunneberg, R. Granich, and P. Nunn, HIV Infection???Associated Tuberculosis: The Epidemiology and the Response, Clinical Infectious Diseases, vol.50, issue.s3, pp.201-208, 2010.
DOI : 10.1086/651492

P. Rohani, C. Green, N. Mantilla-beniers, and B. Grenfell, Ecological interference between fatal diseases, Nature, vol.422, issue.6934, pp.885-893, 1979.
DOI : 10.1038/nature01542

R. Morrow, N. Gutensohn, and P. Smith, Epstein-Barr virus-malaria interaction models for Burkitt ' s lymphoma: implications for preventive trials Epstein- Barr virus-malaria interaction models for Burkitt ' s lymphoma: implications for preventive trials 1, pp.667-676, 1976.

A. Moormann, C. Snider, and K. Chelimo, The company malaria keeps, Current Opinion in Infectious Diseases, vol.24, issue.5, pp.435-476, 2011.
DOI : 10.1097/QCO.0b013e328349ac4f
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265160

A. Chêne, A Molecular Link between Malaria and Epstein???Barr Virus Reactivation, PLoS Pathogens, vol.3, issue.6, p.80, 2007.
DOI : 1475-2875(2004)003[0050:OEOPFE]2.0.CO;2

R. Küppers, B cells under influence: transformation of B cells by Epstein???Barr virus, Nature Reviews Immunology, vol.3, issue.10, pp.801-813, 2003.
DOI : 10.1038/nri1201

J. Dups, M. Pepper, and I. Cockburn, Antibody and B cell responses to Plasmodium sporozoites, Frontiers in Microbiology, vol.33, issue.e1000770, p.625, 2014.
DOI : 10.1016/j.it.2012.04.003
URL : http://doi.org/10.3389/fmicb.2014.00625

M. Madeleine, NIH public access, Int J Cancer, vol.125, pp.2621-2630, 2013.

I. Silins, Chlamydia trachomatis infection and persistence of human papillomavirus, International Journal of Cancer, vol.28, issue.1, pp.110-115, 2005.
DOI : 10.1002/ijc.20970

E. Fukuda, Activation of lipid metabolism contributes to interleukin-8 production during, Society, vol.73, pp.4017-4041, 2005.

H. Harizi, M. Juzan, V. Pitard, J. Moreau, and N. Gualde, Cyclooxygenase-2-Issued Prostaglandin E2 Enhances the Production of Endogenous IL-10, Which Down-Regulates Dendritic Cell Functions, The Journal of Immunology, vol.168, issue.5, pp.2255-63, 2002.
DOI : 10.4049/jimmunol.168.5.2255

J. Paavonen and M. Lehtinen, Chlamydial pelvic inflammatory disease, Human Reproduction Update, vol.2, issue.6, pp.519-548, 1996.
DOI : 10.1093/humupd/2.6.519

P. Gautret, Local and International Implications of Schistosomiasis Acquired in Corsica, France, Emerging Infectious Diseases, vol.21, issue.10, pp.1865-1873, 2015.
DOI : 10.3201/eid2110.150881

O. Ossai, Bacteriuria and urinary schistosomiasis in primary school children in rural communities in Enugu State, Pan Afr Med J, vol.18, pp.4-8, 2014.
DOI : 10.11604/pamjs.supp.2014.18.1.4169
URL : http://dx.doi.org/10.1016/j.ijid.2014.03.414

O. Adeyeba and S. Ojeaga, Urinary Schistosomiasis and concomitant urinary tract pathogens among school children in metropolitan Ibadan, Afr J Biomed Res, vol.5, pp.103-111, 2002.
DOI : 10.4314/ajbr.v5i3.53993
URL : https://www.ajol.info/index.php/ajbr/article/download/53993/42537

Y. Hsieh, C. Fu, and M. Hsieh, Helminth-Induced Interleukin-4 Abrogates Invariant Natural Killer T Cell Activation-Associated Clearance of Bacterial Infection, Infection and Immunity, vol.82, issue.5, pp.2087-97, 2014.
DOI : 10.1128/IAI.01578-13

C. Davis, M. Cohen, M. Gruber, M. Anderson, and M. Warren, Urothelial hyperplasia and neoplasia: a response to chronic urinary tract infection in rats, J Urol, vol.132, pp.1025-1056, 1984.

N. Ma, Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection, Biochemical and Biophysical Research Communications, vol.414, issue.2, pp.344-353, 2011.
DOI : 10.1016/j.bbrc.2011.09.073

S. Kamal, Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni, Liver International, vol.20, issue.4, pp.281-290, 2000.
DOI : 10.1034/j.1600-0676.2000.020004281.x

K. Wakeham, Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women, Infectious Agents and Cancer, vol.6, issue.1, p.15, 2011.
DOI : 10.1002/ijc.10817
URL : http://doi.org/10.1186/1750-9378-6-15

M. Iaria, Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients, Clinical Microbiology and Infection, vol.21, issue.6, pp.9-603, 2015.
DOI : 10.1016/j.cmi.2015.01.025

H. Murata, Helicobacter bilis infection in biliary tract cancer, Alimentary Pharmacology and Therapeutics, vol.160, issue.s1, pp.90-94, 2004.
DOI : 10.1126/science.1067147

P. Pisani, Cross-Reactivity between Immune Responses to Helicobacter bilis and Helicobacter pylori in a Population in Thailand at High Risk of Developing Cholangiocarcinoma, Clinical and Vaccine Immunology, vol.15, issue.9, pp.1363-1371, 2008.
DOI : 10.1128/CVI.00132-08

K. Mossman and A. Ashkar, Herpesviruses and the Innate Immune Response, Viral Immunology, vol.18, issue.2, pp.267-81, 2005.
DOI : 10.1089/vim.2005.18.267

E. Barnes, Diseases and human evolution, 2005.

K. Oikonomopoulou, D. Brinc, K. Kyriacou, and E. Diamandis, Infection and Cancer: Revaluation of the Hygiene Hypothesis, Clinical Cancer Research, vol.19, issue.11, pp.2834-2875, 2013.
DOI : 10.1158/1078-0432.CCR-12-3661

K. Smith, H. Hanson, G. Mineau, and S. Buys, Effects of BRCA1 and BRCA2 mutations on female fertility, Proceedings of the Royal Society B: Biological Sciences, vol.117, issue.6, pp.1389-95, 2012.
DOI : 10.1002/ijc.21273

R. Medzhitov, Origin and physiological roles of inflammation, Nature, vol.21, issue.7203, pp.428-463, 2008.
DOI : 10.1038/nature07201

K. A. Lee, Linking immune defenses and life history at the levels of the individual and the species, Integrative and Comparative Biology, vol.46, issue.6, pp.1000-1015, 2006.
DOI : 10.1093/icb/icl049

B. Walker, L. Figgs, and S. Zahm, Differences in cancer incidence, mortality, and survival between African Americans and whites, Environmental Health Perspectives, vol.103, issue.Suppl 8, pp.275-81, 1995.
DOI : 10.1289/ehp.95103s8275
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1518956

O. Byrne, K. Dalgleish, and A. , Evolution, immune response, and cancer, The Lancet, vol.356, issue.9234, pp.1033-1037, 2000.
DOI : 10.1016/S0140-6736(05)72656-8

C. Finlay, K. Walsh, and K. Mills, Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases, Immunological Reviews, vol.51, issue.Suppl, pp.206-236, 2014.
DOI : 10.1111/imr.12164

M. Botelho, P. Oliveira, C. Lopes, C. Da-costa, J. Machado et al., Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium, Urologic Oncology: Seminars and Original Investigations, vol.29, issue.6, pp.809-823, 2015.
DOI : 10.1016/j.urolonc.2009.09.017

S. Perry, Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis, PLoS ONE, vol.5, issue.1, p.8804, 2010.
DOI : 10.1371/journal.pone.0008804.s007
URL : http://doi.org/10.1371/journal.pone.0008804

S. Gillespie, Tuberculosis: evolution in millennia and minutes, Biochemical Society Transactions, vol.35, issue.5, pp.9-12, 2007.
DOI : 10.1042/BST0351317

M. Blaser, Disappearing Microbiota: Helicobacter pylori Protection against Esophageal Adenocarcinoma, Cancer Prevention Research, vol.1, issue.5, pp.308-319, 2008.
DOI : 10.1158/1940-6207.CAPR-08-0170

R. Schwabe and C. Jobin, The microbiome and cancer, Nature Reviews Cancer, vol.109, issue.11, pp.800-812, 2013.
DOI : 10.1038/nrc3610

H. Ledford, The killer within, 2014.

I. Mellman, G. Coukos, and G. Dranoff, Cancer immunotherapy comes of age, Nature, vol.9, issue.7378, pp.480-489, 2011.
DOI : 10.1038/nature10673

B. Lichty, C. Breitbach, D. Stojdl, and J. Bell, Going viral with cancer immunotherapy, Nature Reviews Cancer, vol.15, issue.8, pp.559-67, 2014.
DOI : 10.1038/nrc3770

H. Qi, Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice, Immunobiology, vol.220, issue.1, pp.54-63, 2015.
DOI : 10.1016/j.imbio.2014.09.002

E. Calle and M. Thun, Obesity and cancer, BMJ, vol.335, issue.7630, pp.6365-78, 2004.
DOI : 10.1136/bmj.39384.472072.80

M. Mostafa and S. Sheweita, Relationship between Schistosomiasis and Bladder Cancer Evidence Supporting The Relationship Between Schistosomiasis And Bladder, pp.97-111, 1999.

B. Choi, J. Han, S. Hong, and K. Lee, Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis, Clinical Microbiology Reviews, vol.17, issue.3, pp.540-52, 2004.
DOI : 10.1128/CMR.17.3.540-552.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC452546

Z. Hausen and H. , The search for infectious causes of human cancers: Where and why, Virology, vol.392, issue.1, pp.1-10, 2009.
DOI : 10.1016/j.virol.2009.06.001

R. Aziz, M. Khalifa, and R. Sharaf, Contaminated water as a source of Helicobacter pylori infection: A review, Journal of Advanced Research, vol.6, issue.4, pp.539-586, 2013.
DOI : 10.1016/j.jare.2013.07.007

P. Ewald, S. Ewald, and H. , Infection, mutation, and cancer evolution, Journal of Molecular Medicine, vol.145, issue.Suppl 1, pp.535-576, 2012.
DOI : 10.1007/s00109-012-0891-2

D. Parkin, The global health burden of infection-associated cancers in the year 2002, International Journal of Cancer, vol.291, issue.12, pp.3030-3074, 2006.
DOI : 10.1002/ijc.21731

D. Martel and C. , Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, The Lancet Oncology, vol.13, issue.6, pp.607-622, 2012.
DOI : 10.1016/S1470-2045(12)70137-7

S. Russell, K. Peng, and J. Bell, Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-70, 2012.
DOI : 10.1038/nbt.2287

J. Bell and G. Mcfadden, Viruses for Tumor Therapy, Cell Host & Microbe, vol.15, issue.3, pp.260-265, 2014.
DOI : 10.1016/j.chom.2014.01.002
URL : http://doi.org/10.1016/j.chom.2014.01.002

H. Ledford, Cancer-fighting viruses near market, Nature, vol.526, 2015.
DOI : 10.1038/526622a

Y. Kim, Q. Lin, P. Glazer, and Z. Yun, Hypoxic Tumor Microenvironment and Cancer Cell Differentiation, Current Molecular Medicine, vol.9, issue.4, pp.425-459, 2010.
DOI : 10.2174/156652409788167113
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824923

N. Agrawal, Bacteriolytic therapy can generate a potent immune response against experimental tumors, Proceedings of the National Academy of Sciences, vol.22, issue.6, pp.15172-15179, 2004.
DOI : 10.1200/JCO.2004.10.041
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC523456

N. Roberts, Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses, Science Translational Medicine, vol.88, issue.6, pp.249-111, 2014.
DOI : 10.1177/0300985810390717
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399712

J. Palefsky and E. Holly, Chapter 6: Immunosuppression and Co-infection with HIV, JNCI Monographs, vol.2003, issue.31, pp.5-10, 2003.
DOI : 10.1093/oxfordjournals.jncimonographs.a003481
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.543.5312

S. Gopal, Moving Forward in HIV-Associated Cancer, Journal of Clinical Oncology, vol.32, issue.9, pp.876-80, 2014.
DOI : 10.1200/JCO.2013.53.1376
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948093

E. Mesri, E. Cesarman, and C. Boshoff, Kaposi's sarcoma and its associated herpesvirus, Nature Reviews Cancer, vol.311, issue.10, pp.707-726, 2010.
DOI : 10.1038/nrc2888

Z. Chirenje, HIV and cancer of the cervix, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.19, issue.2, pp.269-76, 2005.
DOI : 10.1016/j.bpobgyn.2004.10.002

C. Gur, Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack, Immunity, vol.42, issue.2, 2015.
DOI : 10.1016/j.immuni.2015.01.010

J. Spencer, Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10, Journal of Virology, vol.76, issue.3, pp.1285-92, 2002.
DOI : 10.1128/JVI.76.3.1285-1292.2002

C. Cobbs, Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis, Herpesviridae, vol.2, issue.1, p.10, 2011.
DOI : 10.1128/JVI.76.3.1285-1292.2002

W. Coley, The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus Prodigiosus), 1909.

M. Karin and F. Greten, NF-??B: linking inflammation and immunity to cancer development and progression, Nature Reviews Immunology, vol.100, issue.10, pp.749-59, 2005.
DOI : 10.1038/nri1703

P. Gontero, The Role of Bacillus Calmette-Gu??rin in the Treatment of Non???Muscle-Invasive Bladder Cancer, European Urology, vol.57, issue.3, pp.410-439, 2010.
DOI : 10.1016/j.eururo.2009.11.023

P. Huang, Efficacy of intravesical bacillus Calmette-Guérin therapy against tumor immune escape in an orthotopic model of bladder cancer, Exp Ther Med, vol.9, pp.162-168, 2015.